. "Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor\u2013positive advanced breast cancer" . "28" . "7"^^ . "Pendergrass, Kelly" . . "0732-183X" . "1"^^ . . . "000283056400027" . "Sapunar, Francisco" . . "RIV/00064165:_____/10:8258" . "Journal of Clinical Oncology" . . . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "30" . "Bondarenko, Igor, N." . "Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor\u2013positive advanced breast cancer"@en . "Garnett, Sally" . "RIV/00064165:_____/10:8258!RIV11-MZ0-00064165" . "Annotation: Summary - The CONFIRM trial has shown a statistically significant increase in TTP for F500 compared with F250 in postemenopausal women, without increase in toxicity."@en . "Petru\u017Eelka, Lubo\u0161" . "Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor\u2013positive advanced breast cancer"@en . "Khasanov, Rustem" . . "Lichinitser, Mikhail, R." . "Pedrini, Jose, L." . "Annotation: Summary - The CONFIRM trial has shown a statistically significant increase in TTP for F500 compared with F250 in postemenopausal women, without increase in toxicity." . . "Martin, Miguel" . . . . . "Breast cancer; postmenopausal women; fulvestrant; estrogen; CONFIRM trial"@en . "Results of the CONFIRM phase IIItrial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor\u2013positive advanced breast cancer" . "15"^^ . "285079" . . . "Torres, Roberto" . "V" . "[B698155702A6]" . "Verhoeven, Didier" . "Jerusalem, Guy" . . "Smirnova, Iya" . "Di Leo, Angelo" . "Lindemann, Justin, P. O." .